RHCluster4GR: Short-term Telehealth Follow up After Hospital Discharge for Chronic Obstructive Pulmonary Disease Exacerbation
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate whether the introduction of a short-term telemonitoring program for chronic obstructive pulmonary disease (COPD) patients discharged from the hospital after disease exacerbation produces benefits in terms of a reduction in hospital readmissions and health related quality of life. In addition the trials evaluate the economical and organisational impact of the services and examine their acceptability by patients and health professionals.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The purpose of this study is to the evaluate the use of a close phone-based tele-monitoring platform will reflected by less hospital re-admissions, will change their generic and disease specific quality of life compared with usual care. Following this; it is also hypothesized that this will also lead to less patients' deaths. In addition the patients' satisfaction using the telemedicine service will be studied. A Cost-Effective Analysis will evaluate the tele-health service compared with the usual care from the health and social perspective.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: Usual care Patients in the control group receive usual care and visit the outpatient department at 4 and at 12 weeks after discharge when pulse rate, oxygen saturation and spirometry is performed. In the case of clinical deterioration during the study, the patients contact as usual their general practitioner. Usual care of COPD patients consists of regular visits to the specialist or primary care clinics every time a medication change is made or a medical examination is needed |
|
| Experimental: Telemonitoring
|
Procedure: Telemonitoring
Within 24 hours after patient's discharge, the telemedicine equipment is installed at the patient's home and patients are trained in the use of the equipment. Patients are followed by a dedicated telehealth centre. Patients at home are asked to fill out each morning the CAT questionnaire and to record extra use of COPD relief medications. Patients in stable conditions perform telespirometry and teleoximetry at 4 and 12 weeks. When a clinical worsening is detected (increase in CAT score by 5 points or higher on two consecutive days) the patient is contacted and asked to perform ad hoc telespirometry and teleoximetry and to send the data to the telehealth centre.
|
Outcome Measures
Primary Outcome Measures
- Number of hospital readmissions [3 months period]
Number of hospital readmissions after the hospital discharged of the patient after a COPD exacerbation
Secondary Outcome Measures
- Health related quality of life of the patients as measured by the SF-36 version 2 questionnaire [3 months - at the entry point of the intervention and the end.]
Health related quality of life of the patients as measured by the SF-36 version 2 questionnaire
- Hospital anxiety and depression scale HADS [3 months - at the entry point of the intervention and the end.]
Hospital anxiety and depression scale HADS
- Health status, measured with the St. George's Respiratory Questionnaire SGRQ [3 months - at the entry point of the intervention and the end.]
Health status, measured with the St. George's Respiratory Questionnaire SGRQ
- Lung condition as measured by FEV1 [1 month after the hospital discharge.]
Lung condition as measured by FEV1
- Mortality [3 months period]
Mortality
- Patients' Acceptance-Satisfaction measured by the WSD Questionnaire [at the 3rd month of the tele-monitoring]
Patients' Acceptance-Satisfaction of telemonitoring measured by the Whole System Demonstrators Questionnaire , for the intervention arm (telemonitoring)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Exacerbation of COPD according to the GOLD guidelines
-
Age > 40 years
-
Capability to use the devices provided
-
Willing to participate
Exclusion Criteria:
included in previous COPD monitoring study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Pulmonary Department - Regional University Hospital of Larisa | Larisa | Thessaly | Greece | 41110 |
Sponsors and Collaborators
- Regional Health Authority of Sterea & Thessaly
- Ministry for Health and Social Solidarity, Greece
- Municipality of Trikala, Greece
- e-Trikala S.A.
- Cities Net SA
- Institute of Biomedical Research & Technology, Larissa, Greece
- Institute of Communications and Computer Systems, Athens, Greece
- Alexander Technological Educational Institute, Thessaloniki, Greece
- University of Macedonia, Thessaloniki, Greece
- University of Thessaly
Investigators
- Principal Investigator: Konstantinos Gourgoulianis, MD, PhD, Pulmonary Department - University Hospital of Larisa
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
- FR2017
- EC Grant Agreement 250487